MRNA and miRNA analyses in cytologically positive endobronchial ultrasound-guided transbronchial needle aspiration: Implications for molecular staging in lung cancer patients

Cancer Cytopathology

Volumn 122, Issue 4, 2014, Pages 292-298

  Plönes, Till ^a   Elze, Mirjam ^b   Kayser, Gian ^b   Pfeifer, Dietmar ^b   Burger, Meike ^b   Zissel, Gernot ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Biomarker; EBUS TBNA; Epigenetic; Lobectomy; MicroRNA; Outcome; RNA integrity number (RIN); Survival

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 155; MICRORNA 200C; MICRORNA 21; MICRORNA 34A; BIOLOGICAL MARKER; TUMOR MARKER;

ADULT; ARTICLE; BENIGN TUMOR; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; ENDOBRONCHIAL ULTRASONOGRAPHY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MEDIASTINUM LYMPHADENOPATHY; PRIORITY JOURNAL; RNA ANALYSIS; RNA ISOLATION; RNA STABILITY; TRANSBRONCHIAL ASPIRATION; AGED; BRONCHOSCOPY; CASE CONTROL STUDY; COMPARATIVE STUDY; EBUS-TBNA; ENDOSCOPIC ECHOGRAPHY; EPIGENETIC; FINE NEEDLE ASPIRATION BIOPSY; GENETICS; IMAGE GUIDED BIOPSY; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; OUTCOME; PATHOLOGY; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; RNA INTEGRITY NUMBER (RIN); SENSITIVITY AND SPECIFICITY; SURVIVAL; TUMOR INVASION;

BIOMARKER; EBUS-TBNA; EPIGENETIC; LOBECTOMY; MICRORNA; OUTCOME; RNA INTEGRITY NUMBER (RIN); SURVIVAL;

ADULT; AGED; BIOPSY, FINE-NEEDLE; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; ENDOSONOGRAPHY; FEMALE; HUMANS; IMAGE-GUIDED BIOPSY; LUNG NEOPLASMS; LYMPH NODES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84901700596     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21398     Document Type: Article

References (33)

1. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893-1907.
2. Crino L, Weder W, van Meerbeeck J, Felip E. Early stage and locally advanced (non-metastatic) non-smal cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v103-v115.
3. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32:1-8. (Pubitemid 46874948)
4. Lemaire A, Nikolic I, Petersen T, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg. 2006;82:1185-1189.
5. Adebibe M, Jarral OA, Shipolini AR, McCormack DJ. Does video-assisted mediastinoscopy have a better lymph node yield and safety profile than conventional mediastinoscopy? Interact Cardiovasc Thorac Surg. 2012;14:316-319.
6. Andrade RS, Groth SS, Rueth NM, D'Cunha J, Pambuccian SE, Maddaus MA. Evaluation of mediastinal lymph nodes with endobronchial ultrasound: the thoracic surgeon's perspective. J Thorac Cardiovasc Surg. 2010;139:578-582.
7. Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 2006;61:795-798. (Pubitemid 44369405)
8. Vincent BD, El-Bayoumi E, Hoffman B, et al. Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg. 2008;85:224-230. (Pubitemid 350265800)
9. Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer. 2005;50:347-354.
10. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718-1723. (Pubitemid 27260108)
11. Groth SS, Andrade RS. Endobronchial and endoscopic ultrasoundguided fine-needle aspiration: a must for thoracic surgeons. Ann Thorac Surg. 2010;89:S2079-S2083.
12. Sienel W, Dango S, Ehrhardt P, Eggeling S, Kirschbaum A, Passlick B. The future in diagnosis and staging of lung cancer. Molecular techniques. Respiration. 2006;73:575-580. (Pubitemid 44481470)
13. Cucuruz B, Dango S, Jurinovic V, et al. MAGE qPCR improves the sensitivity and accuracy of EBUS-TBNA for the detection of lymphatic cancer spread. J Thorac Oncol. 2012;7:690-707.
14. Dango S, Cucuruz B, Mayer O, et al. Detection of disseminated tumour cells in mediastinoscopic lymph node biopsies and endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected lung cancer. Lung Cancer. 2010;68:383-388.
15. Dango S, Wang XT, Gold M, et al. Expression of melanomaantigen- A (MAGE-A) in disseminated tumor cells in regional lymph nodes of patients with operable non-small cell lung cancer. Lung Cancer. 2010;67:290-295.
16. Mraz M, Malinova K, Mayer J, Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun. 2009;390:1-4.
17. Jung M, Schaefer A, Steiner I, et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem. 2010;56:998-1006.
18. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9:189-198. (Pubitemid 43357945)
19. Yang M, Shen H, Qiu C, et al. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 2013;49:604-615.
20. Huang W, Hu J, Yang DW, et al. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. Am J Respir Crit Care Med. 2012;186:1160-1167.
21. Voortman J, Goto A, Mendiboure J, MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res. 2010;70:8288-8298.
22. Liu XG, Zhu WY, Huang YY, et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol. 2012;29:618-626.
23. Lussier YA, Xing HR, Salama JK, et al. MicroRNA expression characterizes oligometastasis(es). PLoS One. 2011;6:e28650.
24. Berghmans T, Ameye L, Willems L, et al. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer. 2013;82:340-345.
25. Schroeder A, Mueller O, Stocker S, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7:3.
26. Underwood JM, Townsend JS, Tai E, et al. Racial and regional disparities in lung cancer incidence. Cancer. 2012;118:1910-1918.
27. Fibla JJ, Cassivi SD, Decker PA, et al. Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030). Eur J Cardiothorac Surg. 2013;43: 911-914
28. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2:706-714. (Pubitemid 47357522)
29. Xi L, Coello MC, Litle VR, et al. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res. 2006;12:2484-2491.
30. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med. 2006;27:126-139.
31. Lebanony D, Benjamin H, Gilad S, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small cell lung carcinoma. J Clinical Oncol. 2009;27:2030-2037.
32. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res. 2010;16:610-619.
33. Barbareschi M, Cantaloni C, Del Vescovo V, et al. Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Path. 2011;136:773-782.